Loading clinical trials...
Loading clinical trials...
Subjects were randomly assigned to groups for treatment with either an EGF-containing ointment (the study group) or the vehicle alone (petrolatum; the control group). The EGF ointment included recombi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hallym University Kangnam Sacred Heart Hospital
NCT05967689 · Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
NCT07222215 · Estrogen-receptor-positive Breast Cancer, Metastatic Breast Cancer, and more
NCT07513727 · Gingival Hyperpigmentation, Gingival Melanin Pigmentation
NCT05735080 · Breast Cancer, Breast Cancer Metastatic, and more
NCT06348134 · Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, HER2-positive Breast Cancer, and more
Kangnam Sacred Heart Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions